Yujuan Wang

Dr. Yujuan Wang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Materials
Verified
Journal Article
Open access
PDF file
FCFajun Chen
Fajun Chen
JHJian Han
Jian Han
ZGZeyong Guo
Zeyong Guo
CMChongjing Mu
Chongjing Mu
CYChuandi Yu
Chuandi Yu
JWJunfeng Wang
Junfeng Wang
Infectious bone defects present a major challenge in the clinical setting currently. In order to address this issue, it is imperative to explore the development of bone tissue engineering scaffolds that are equipped with both antibacterial and bone regenerative capabilities. In this study, we fabricated antibacterial scaffolds using a silver nanoparticle/poly lactic-co-glycolic acid (AgNP/PLGA) material via a direct ink writing (DIW) 3D printing technique. The scaffolds’ microstructure, mechanical properties, and biological attributes were rigorously assessed to determine their fitness for repairing bone defects. The surface pores of the AgNPs/PLGA scaffolds were uniform, and the AgNPs were evenly distributed within the scaffolds, as confirmed via scanning electron microscopy (SEM). Tensile testing confirmed that the addition of AgNPs enhanced the mechanical strength of the scaffolds. The release curves of the silver ions confirmed that the AgNPs/PLGA scaffolds released them continuously after an initial burst. The growth of hydroxyapatite (HAP) was characterized via SEM and X-ray diffraction (XRD). The results showed that HAP was deposited on the scaffolds, and also confirmed that the scaffolds had mixed with the AgNPs. All scaffolds containing AgNPs exhibited antibacterial properties against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). A cytotoxicity assay using mouse embryo osteoblast precursor cells (MC3T3-E1) showed that the scaffolds had excellent biocompatibility and could be used for repairing bone tissue. The study shows that the AgNPs/PLGA scaffolds have exceptional mechanical properties and biocompatibility, effectively inhibiting the growth of S. aureus and E. coli. These results demonstrate the potential application of 3D-printed AgNPs/PLGA scaffolds in bone tissue engineering.

17 May 2015 in The Protein Journal
Verified
Journal Article
Closed access
PDF file
XWXiaoming Wang
Xiaoming Wang
ZMZongjun Mu
Zongjun Mu
YLYan Li
Yan Li
YBYunchen Bi
Yunchen Bi
YWYujuan Wang
Yujuan Wang

Verified
Journal Article
Open access
PDF file
QSQi Sun
Qi Sun
HJHuiling Jia
Huiling Jia
CCCheng Cheng
Cheng Cheng
YWYujuan Wang
Yujuan Wang
JWJun Wang
Jun Wang
Vascular endothelial injury is important in anthracycline-induced cardiotoxicity. Anthracyclines seriously damage the mitochondrial function and mitochondrial homeostasis. In this study, we investigated the damage of epirubicin to vascular endothelial cells and the protective role of metformin from the perspective of mitochondrial homeostasis. We found that epirubicin treatment resulted in DNA double-strand breaks (DSB), elevated reactive oxygen species (ROS) production, and excessive Angiotensin II release in HUVEC cells. Pretreatment with metformin significantly mitigated the injuries caused by epirubicin. In addition, inhibited expression of Mitochondrial transcription factor A (TFAM) and increased mitochondria fragmentation were observed in epirubicin-treated cells, which were partially resumed by metformin pretreatment. In epirubicin-treated cells, knockdown of TFAM counteracted the attenuated DSB formation due to metformin pretreatment, and inhibition of mitochondrial fragmentation with Mdivi-1 decreased DSB formation but increased TFAM expression. Furthermore, epirubicin treatment promoted mitochondrial fragmentation by stimulating the expression of Dynamin-1-like protein (DRP1) and inhibiting the expression of Optic atrophy-1(OPA1) and Mitofusin 1(MFN1), which could be partially prevented by metformin. Finally, we found metformin could increase TFAM expression and decrease DRP1 expression in epirubicin-treated HUVEC cells by upregulating the expression of calcineurin/Transcription factor EB (TFEB). Taken together, this study provided evidence that metformin treatment was an effective way to mitigate epirubicin-induced endothelial impairment by maintaining mitochondrial homeostasis.

22 December 2023 in Chinese Chemical Letters
Verified
Journal Article
Closed access
JZJing Zhang
Jing Zhang
CWCharles Wang
Charles Wang
YZYaoyao Zhang
Yaoyao Zhang
HXHaining Xia
Haining Xia
YWYujuan Wang
Yujuan Wang
JWJunfeng Wang
Junfeng Wang

Verified
Journal Article
Open access
PDF file
YWYujuan Wang
Yujuan Wang
YZYaoyao Zhang
Yaoyao Zhang
ZLZehua Li
Zehua Li
JWJunfeng Wang
Junfeng Wang
JMJD8 is a protein from the JMJD family that only has the JmjC domain. Studies on the function of JMJD8 indicate that JMJD8 is involved in signaling pathways, including AKT/NF-κB, and thus affects cell proliferation and development. Here, we reported the activity of JMJD8 as a non-histone demethylase. We investigated the demethylation of JMJD8 on trimethylated lysine of AKT1 in vivo and in vitro using trimethylated AKT1 short peptide and AKT1 protein, and we tracked the regulation of JMJD8 on AKT1 activity at the cellular level. The results showed that JMJD8, a mini lysine demethylase, altered AKT1 protein function via changing its degree of methylation.

8 April 2024 in FEBS Letters
Verified
Journal Article
Closed access
ZWZiwei Wu
Ziwei Wu
LLLing Li
Ling Li
LZLina Zhu
Lina Zhu
RWRunhan Wang
Runhan Wang
YDYingkui Dong
Yingkui Dong
LZLei Zhu
Lei Zhu